Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $518.3050 (0.01%) ($511.1100 - $518.3050) on Fri. Jan. 15, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.8% (three month average) | RSI | 66 | Latest Price | $518.3050(0.01%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.8% a day on average for past five trading days. | Weekly Trend | REGN advances 3.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(51%) XLV(43%) SPLV(37%) DIA(36%) IVW(36%) | Factors Impacting REGN price | REGN will decline at least -0.9% in a week (0% probabilities). VIXM(-21%) TBT(-7%) VXX(-6%) UUP(-6%) IGOV(-6%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.9% (StdDev 1.8%) | Hourly BBV | 0.9 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $511.7(1.29%) | 10 Day Moving Average | $498.3(4.01%) | 20 Day Moving Average | $493.67(4.99%) | To recent high | -13.6% | To recent low | 10.3% | Market Cap | $54.955b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |